Terns Pharmaceuticals Inc Share Price

NASDAQ: TERN

Small Cap

$7.13

-0.10

(-1.31%)

as on September 16, 2025 at 1:29 am IST

$₹

Terns Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$7.01
Day's Price Range
$7.28
$7.13
1.68%
Downside
2.10%
Upside
52 Week's Low
52 Week's High
$1.87
52-Week Price Range
$10.7
$7.13
73.84%
Downside
50.07%
Upside

Terns Pharmaceuticals Inc share price movements today

Previous Close: $7.23
Open: $7.20
Volume: 882.5K
Day's Low - High: $7.01 - $7.28
52 Week Low - High: $1.87 - $10.7

Terns Pharmaceuticals Inc Historical Returns

1 Month Return: + 2.55 %
3 Month Return: + 86.34 %
1 Year Return: -19.26 %
3 Year Return: + 12.62 %
5 Year Return: 0 %

Terns Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Terns Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$632.7M

EPS (TTM)

-1.1286

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-105.5M

Revenue (TTM)

1.0M

Profit Margin

0.00%

Return On Equity TTM

117227200.00%

Terns Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Terns Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Terns Pharmaceuticals Inc	BUY	$632.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Terns Pharmaceuticals Inc Stock including INR - Dollar returns

The Terns Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Terns Pharmaceuticals Inc investment value today

Current value as on today

₹84,561

Returns

₹15,439

(-15.44%)

Returns from Terns Pharmaceuticals Inc Stock

₹20,424 (-20.42%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Terns Pharmaceuticals Inc Stock

Based on 14 analysts

BUY

78.57%

Buy

21.43%

Hold

0.00%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Terns Pharmaceuticals Inc. Average target price of $18.21

Terns Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Terns Pharmaceuticals Inc.

What analysts predicted

60.85%UPSIDE

Target Price

$18.21

Current Price

$7.13

Analyzed by

14 Analysts

Target

$18.21

Terns Pharmaceuticals Inc target price $18.21, a slight upside of 60.85% compared to current price of $7.13. According to 14 analysts rating.

Terns Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Terns Pharmaceuticals Inc Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-88% versus previous 30 day period

Terns Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	-	-	-	-
Gross Profit	0	0	0	1	0	0	-	-	-	0
Operating Income	-24	-21	-33	-24	-25	-25	-24	-25	-27	-27
EBITDA	-24	-21	-33	-23	-25	-25	-24	-25	-27	-23
Interest Expense	2	-	-	2	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-21	-17	-29	-20	-22	-22	-21	-21	-23	-24
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-21	-17	-29	-21	-22	-22	-21	-21	-23	-24
Net Profit Margin	0.00%	0.00%	0.00%	-1589.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Terns Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	1	-	-	-
Gross Profit	0	0	0	1	-1	0	-
Operating Income	-18	-70	-37	-49	-62	-102	-101
EBITDA	-18	-35	-36	-49	-60	-102	-87
Interest Expense	-	1	2	0	2	-	-
Depreciation	0	0	0	0	1	0	0
Income Before Tax	-18	-68	-39	-49	-59	-89	-88
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-17	-68	-40	-50	-60	-90	-88
Net Profit Margin	0.00%	0.00%	0.00%	-5015.80%	0.00%	0.00%	0.00%

Terns Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	-29	-21	-22	-22	-21	-21	-23	-24
Operating Cash Flow	-12	-20	-19	-22	-16	-16	-14	-24	-18
Investing Cash Flow	-90	-22	47	7	42	31	-94	1	25
Financing Cash Flow	0	0	13	-	0	163	0	0	0
Change in Cash	-103	-43	42	-14	26	178	-108	-22	6

Terns Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-68	-40	-50	-60	-90	-88
Operating Cash Flow	-66	-29	-41	-49	-67	-70
Investing Cash Flow	-3	6	-119	-22	-37	-12
Financing Cash Flow	0	85	134	167	41	163
Change in Cash	-70	62	-27	95	-63	81

Global Institutional Holdings in Terns Pharmaceuticals Inc

Funds	Holdings
Soleus Capital Management, L.P.	9.34%
Orbimed Advisors, LLC	8.65%
Morgan Stanley - Brokerage Accounts	8.13%
Vivo Capital, LLC	7.88%
BlackRock Inc	6.52%

See all

Insights on Terns Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 100.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 94.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TERN stock has moved down by -5.6%

About Terns Pharmaceuticals Inc

terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of drugs that are optimized against clinically-validated targets. based in san mateo, california and shanghai, terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in china and globally.

Organisation	Terns Pharmaceuticals Inc
Headquarters	1065 East Hillsdale Boulevard, Foster City, CA, United States, 94404
Industry	Services
CEO	Ms. Amy L. Burroughs M.B.A.
E-voting on shares	Click here to vote

Key Management of Terns Pharmaceuticals Inc

Name	Title
Mr. Scott Harris	Chief Development Officer
Ms. Debra Sieminski	Senior Vice President of Medical Affairs
Mr. Andrew W. Gengos	CFO & Head of Corporate Development
Ms. Robin Andrulevich	Chief People Officer
Dr. Jeffrey R. Jasper Ph.D.	Senior Vice President of Research
Dr. Emil T. Kuriakose M.D.	Chief Medical Officer
Ms. Amy L. Burroughs M.B.A.	CEO & Director
Ms. Melita Sun Jung	Chief Business Officer
Ms. Caryn Gordon McDowell J.D.	Chief Legal Officer & Corporate Secretary
Mr. James Kanter	Senior VP of CMC

FAQs

What is Terns Pharmaceuticals Inc share price today?

Terns Pharmaceuticals Inc share price today is $7.13 as on September 16, 2025 at 1:29 am IST at the close of the market. Terns Pharmaceuticals Inc share today touched a day high of $7.28 and a low of $7.01.

What is the 52 week high and 52 week low for Terns Pharmaceuticals Inc share?

Terns Pharmaceuticals Inc share touched a 52 week high of $10.7 on September 19, 2024 and a 52 week low of $1.87 on April 7, 2025. Terns Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $7.13,which is 33.36% down from its 52 week high and 282.31% up from its 52 week low.

What is Terns Pharmaceuticals Inc's market capitalisation today?

Terns Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Terns Pharmaceuticals Inc Stock (TERN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Terns Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Terns Pharmaceuticals Inc Shares that will get you 0.2104 shares as per Terns Pharmaceuticals Inc share price of $7.13 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Terns Pharmaceuticals Inc Stock (TERN) from India?

Indian investors can start investing in Terns Pharmaceuticals Inc (TERN) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 3:56 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Terns Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 3:56 pm IST). Based on Terns Pharmaceuticals Inc share’s latest price of $7.13 as on September 16, 2025 at 1:29 am IST, you will get 1.4025 shares of Terns Pharmaceuticals Inc. Learn more about fractional shares .